Showing posts with label counterfeit medicine. Show all posts
Showing posts with label counterfeit medicine. Show all posts

Monday, December 27, 2010

Counterfeit Drugs More Deadly Than Terrorism


“While 65,000 people have died in the past 40 years as a result of terrorism, fake medicine has killed 200,000 people in China in one year alone.”

Interpol Secretary-General Ronald Noble quoted in a presentation at an anti-counterfeiting conference in Africa.

Thursday, January 28, 2010

Bloomberg: Interpol Investigation Leads to Drug Seizures, Arrests in Asia


Bloomberg News has posted an online story reporting on a huge seizure of millions of counterfeit unit of sale packs of counterfeit medications. The operation coded named Operation Storm II was coordinated by Interpol and included counterfeit medications from the branded manufacturers Pfizer, Bristol-Meyers Squibb and Teva.

The entire Bloomberg News story appears below:

Police seized more than 20 million packs of counterfeit medicines, arrested at least 33 people and closed more than 100 illegal pharmacies in a series of raids in eight Southeast Asian nations coordinated by Interpol.

Counterfeit versions of Pfizer Inc.’s Viagra for erectile dysfunction, Bristol-Myers Squibb Co.’s blood thinner Plavix and Teva Pharmaceutical Industries Ltd.’s morning-after pill Plan B were among the products seized, Aline Plancon, an Interpol officer who coordinated the raids, said Jan. 26 in an e-mail from Jakarta. The haul also included fake aspirin, antibiotics, malaria treatments and hair-loss medicines, she said.

The seizures and arrests, part of an investigation called Operation Storm II, are the second round of raids in two years in Asia as international and local police crackdown on widening sales of fake medicines.

Asia is the world’s biggest producer of all counterfeit products, the Organization for Economic Cooperation and Development said in 2007 report. About 40 percent of 1,047 arrests related to fake drugs worldwide in 2008 were made in Asia, according to the Washington-based Pharmaceutical Security Institute.

In raids between July and November, police in Cambodia, China, Laos, Indonesia, Myanmar, Singapore, Thailand and Vietnam seized more than 12.2 million packs of fake drugs, Plancon said. An additional 8 million packs of medicines that had passed their expiry dates, were unregistered, or had been diverted from their intended destinations were also confiscated, she said.

Authorities from the eight countries involved plan to form a network to exchange information; coordinate enforcement and forensic investigations; and raise awareness in the region, Plancon said. Interpol is also creating a unit focused on fighting fake drugs, she said.
The new unit will help “dismantle the transnational criminals who threaten lives,” Plancon said. “This crime is a plague that needs to be addressed seriously and consistently in each and every country and region of the world.”

In 2008, police seized more than $6.7 million of counterfeit medicines and made 27 arrests in 200 raids across the region as part of Operation Storm I.

To read learn more about anti-counterfeiting technologies that protect the pharmaceutical supply chain, visit: www.xstreamsystems.net.

To read the entire Bloomberg post, follow this link:
http://www.bloomberg.com/apps/news?pid=20601080&sid=aktGpE2o.ohM

Wednesday, November 25, 2009

INTERPOL and World Health Organization: International Operation Combats Online Supply of Counterfeit and Illegal Medicines

In a related story to a previous blog, INTERPOL and the World Health Organization's International Medical Products Anti-Counterfeiting Taskforce (IMPACT) coordinated a 24 country wide operation named Operation Pangea II in response to an ever-increasing number of websites supplying dangerous and illegal medicines and the dangers of buying medicines online.

"Our primary goal in Operation Pangea II is to protect the public by removing counterfeit and illicit medicines from the market, by shutting down illegal sales on the web, and by prosecuting those potentially putting lives of innocent consumers at risk," said INTERPOL Secretary General Ronald K. Noble.

Medicine regulators, police and customs officials around the world worked closely together during the crackdown from November 16th though the 20th, focusing on the three principal components used by illegal websites to conduct trade – the Internet Service Provider (ISP), payment systems and the delivery services.

During the operation, Internet monitoring revealed 751 websites engaged in illegal activity, including offering controlled or prescription only drugs, 72 of which have now been taken down. In addition, more than 16,000 packages were inspected by regulators and customs, 995 packages were seized and nearly 167,000 illicit and counterfeit pills - including antibiotics, steroids and slimming pills, confiscated.

The operation received significant support from the Permanent Forum on International Pharmaceutical Crime (PFIPC) the World Customs Organization, the UK's Medicines and Health Care products Regulatory Agency (MHRA), the US Food and Drug Administration (FDA) and Immigration and Customs Enforcement (ICE), the Royal Canadian Mounted Police and Health Canada.

Countries involved in Operation Pangea II were - Australia, Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Ireland, Israel, Italy, Liechtenstein, Netherlands, New Zealand, Norway, Portugal, Singapore, South Africa, Spain, Sweden, Switzerland, Thailand, UK and the USA.

To read more about this international operation, visit: blog.taragana.com.

Tuesday, November 10, 2009

Fake Meds Lure 7 M Adults in UK - But it could cost them more than just a charge on their credit card!

Pfizer shocked the world early this year when they release anti-counterfeiting campaign in the theaters in the United Kingdom. They are now continuing this campaign for public awareness with posters and commercials on TV. Due to their graphic nature, the commercial was only shown after 11 p.m.

The main message is an elaboration of “Buyer Beware” – especially when it comes to online purchases of medications. In an age where consumers are buying more of their products online, they need to be cautious when it comes to medications.

New research indicating the scale of the counterfeit medicine culture was released last week as part of this hard-hitting campaign to educate the public of the risks involved in purchasing fake medicines from unregulated websites. The Get Real, Get A Prescription public awareness campaign is being launched in a partnership between Pfizer, the Medicines and Healthcare products Regulatory Agency (MHRA), the Royal Pharmaceutical Society of Great Britain (RPSGB), The Patients Association and HEART UK.

More than one in seven British Adults survey (15%) admitted to bypassing the healthcare system to get medication without a prescription. That would equate to around 7 million adults who are gambling with their lives. So why would consumers take this risk? - A majority (60%) of adults agree that they're more trusting of all purchases they make online today compared to five years ago. About one fifth stated they believe offering medications online at discounted pricing is a public service and about a third believe the medication to be true. But 78% of General Practitioners believe this practice puts their patient’s health and potentially their lives at risk, due to the prevalence of counterfeit drugs online.

David Pruce from the Royal Pharmaceutical Society of Great Britain said: "Pharmacists are very concerned about the increase in fake or counterfeit medicines. As expert professionals in medicines and medicines use, we know only too well that fake medication does not work and that it can cause harm. Stay safe by ensuring that you always get your prescriptions dispensed at a registered UK pharmacy. If you want to buy medicines online, always check that you are dealing with a genuine pharmacy. Don't go on face value - some of the illegal sites look very professional but supply dangerous fakes. Check our website for a list of sites that have been awarded the RPSGB's internet pharmacy logo so that you can be sure that you are dealing with a UK registered pharmacy supplying genuine medicines. This campaign is important. We want the UK to be the safest place to obtain medicines."

Consumers can go to http://www.realdanger.co.uk for more information and advice.

To read entire article visit: http://www.medicalnewstoday.com.

Wednesday, October 7, 2009

American Pharmacists Month: Know Your MEDICINE, Know Your Pharmacist

American Pharmacists Month is October and the American Pharmacists Association (APhA) is using the theme of “Know Your MEDICINE, Know Your Pharmacist” as it core message for the month.

One of the APhA’s objectives for the month is - To stress the importance of Knowing Your Medicine and Knowing Your Pharmacist to ensure drug therapy is as safe and effective as possible.

As often blogged about in Secure Pharma Chain Blog, globally the entire pharmaceutical supply chain is facing a proliferating epidemic of counterfeit, adulterated and fraudulent medications which threaten to impact the healthcare of consumers worldwide. Literally hundreds of thousands of people die each year globally, with millions more suffering from the impact of fraudulent drugs that they consume. Domestically, even though the percentage of the supply chain, impacted by counterfeit medications is estimated at 1-3% (well below the global average of 10%) this still means that over 35 million prescriptions are filled with fraudulent drugs each year within the United States.

The pharmacist is a consumer’s primary line of defense in protecting themselves from the impact of fraudulent and counterfeit medications and making certain that their drug therapy is as safe and effective as possible.

Secure Pharma Chain Blog’s Consumer Tips for Maximizing the Safety and Effectiveness of Your Medications:

1. Only buy medications from a licensed pharmacy that has locations near your home.

2. If you buy prescriptions on-line, only buy from licensed on-line pharmacy that is approved by the National Association of Boards of Pharmacy and/or one that is part of a chain or otherwise affiliated with a drug store that you visit regularly.

3. Never buy prescription medications from a source that does not require a physician’s prescription or offers you a physician’s prescription without a physical examination.

4. Develop a rapport with your local pharmacist and visit regularly with them about your medications and your healthcare in general.

5. If you notice that your medications have changed in appearance, smell, taste or otherwise appear different, contact your pharmacist immediately.

6. If you notice side effects that have not been explained to you, or your medications are not properly treating your condition as they have before, notify your pharmacist and physician immediately.

7. Remember, if the price of a medication sounds too good to be true, it probably is.

In today’s current economic climate, there are many who are using healthcare and medications as a way to make a quick buck, it is important that you work with healthcare professionals that diligently protect their patients from nefarious sources of supply that may negatively impact your health.

Wednesday, April 8, 2009

Taiwan Survey Finds 8% of Drug Stores Have Fake Pills

In a March 27th story in the China Post it was reported that the Taiwan Medical Product Anti-Counterfeit Task Force (TMPACT) surveyed pharmacies and consumers and found that 8% of the surveyed pharmacists reported that they had counterfeit pills in their stores.

The survey was conducted in 2008 with over 90% of those surveyed responding to the questionnaire.

According the report, Taiwanese consumers of Viagra, Viartril-S and Reductil are the most at risk for consuming counterfeit medicines. Susceptible and targets in general are afrodyn drugs, diet pills, joint and arthritis pills, stomach pills and vitamins.

TMPACT is currently using authentication technology to identify counterfeit medications and is hoping to work with the Department of Health in the future to combat the issue of fake medications.

Monday, April 6, 2009

Russia: Four Pharma Execs Found Guilty of Counterfeiting 50 Brands of Medicine - Get Slap on the Hand


Four pharmaceutical executives from a prominent Russian pharmaceutical company, Bryntsalov A, were convicted in Moscow of counterfeiting over 50 different brands of medicine but all they got was a slap on the hand. Tatyana Bryntsalova, Oleg Zharov Sergey Novikov, and another executive received a suspended sentence, parole and fines of 30,000 – 50,000 rubles (about $900 - $1,500).

The knock-offs were sophisticated immitations, which made it difficult for doctors or patients to distinguish the fakes from the genuine products. According to police investigators around $2.5 million of medicines were manufactured by the company in 2004 and 2005.

TheraFlu, Viagra, No-Spa, Mezim-Forte, Nootropil and Baralgin are among the American and European drugs that were imitated. So far, however, only the American company Pfizer has indicated that it will take any action to seek restitution from Bryntsalov A.

Some of these medications were found in Russian hospitals. One of the fake medicines, Cavinton, made its way to a large research hospital in Siberia. The doctors there unknowingly administered around 3,000 doses of the fake Cavinton to their patients. The investigation eventually traced the fakes to a warehouse in Moscow registered to Tatyana Bryntsalova.

Tatyana Bryntsalova, former director of Bryntsalov A, is known to have strong political ties in Russia. She is a sister of the pharmaceuticals and vodka business tycoon, Vladimir Bryntsalov, the founder of Bryntsalv A and a former presidential candidate.

To view the entire article visit MosNews.com.

Monday, March 9, 2009

BBC: Seized Drugs 'Were Counterfeit'


The following story about a major counterfeit drug raid in the UK was posted on the BBC Online. This story illustrates how pervasive and relatively common counterfeit and fraudulent medications are becoming within communities and everyday life within developed countries:

More than £250,000 of counterfeit, unlicensed and withdrawn medicines have been seized during raids in Stoke-on-Trent, the drug regulatory agency said.

A woman aged 50 was bailed on suspicion of illegally selling prescription drugs after the morning raids on Tuesday, March 3rd.

The Medicines and Healthcare products Regulatory Agency (MHRA) said a couple in their 60s was being questioned.

It said the drugs were the "tip of the iceberg" of an expected multi-million-pound illegal online medicine business.

For the full story follow this link:
http://news.bbc.co.uk/go/em/fr/-/2/hi/uk_news/england/staffordshire/7924072.stm

Monday, February 23, 2009

Pfizer Pfakes: broken hearted old Men

Charles R. Earl, M.A., ABD CEO, Communication Connections

A recent news item on this web site chronicled the massive distribution of counterfeit Pfizer products in the Mid-East. Actually, the problem is a more global one. Fake pharmaceuticals do not respect boundaries or jurisdictions. Fake drugs and their purveyors do not respect people, either. They insidiously penetrate every market, every demographic, everywhere. Various articles and research papers have identified the real harm done to patients by the nefarious substitution or adulteration of pharmaceuticals.

There is another massive downside to the “faking” industry that is rarely discussed. As a person who has sailed past my sixtieth (60th) birthday in recent years, I play golf, enjoy social activities and have clients who are in their “golden years.” The nest is empty, and perhaps, retirement goals have been achieved. A lifetime of stress and hard work has taken its toll on the body and the mind. As the person begins his glide pattern in life, he discovers that he has heightened energy and new purposes in life. But alas, the body that has been broken and abused for many years will not cooperate. But wait! Viola’ (maybe I should say “Viva”). What once was but a distant dream has now become quite feasible.

The potential for rekindling the romantic lives of these aging warriors has filled them with hope and optimism. Their significant others, while perhaps skeptical in the beginning, may share in their mates’ revivals with gusto and gladness. Then Whammo! Nothing happens. The dreams of reinvigorated lives together become downcast and droopy. The hope for shared love does not spring. The promises of new beginnings fade into distant memories of days gone by.

There are a multitude of snide jokes about the users of Viagra. There is, however, a real cost when the product is counterfeit. It is more than some randy old guy trying to get his jollies at the local bowling alley or cocktail bar. Real people, real couples, real frustration and disappointment color the landscape of people who had hoped to recapture the spark. Maybe they will grasp the hope anyway despite the failure of the drug, but the detour and the delay are unnecessary and avoidable.

Thursday, February 19, 2009

WHAT SHOULD PFIZER DO?

20 Pfizer products are counterfeited worldwide with Lipitor, Norvasco and Viagra topping the list.

The following is a news report that appeared in the Khaleej Times Online, regarding UAE’s efforts to combat faux pharmaceuticals and was authored by Sajila Saseendran and Emily Meredith (sajila@khaleejtimes.com) 15 February 2009.

The plain white boxes with dull grey lettering that line pharmacy shelves are supposed to contain medicine to improve people’s well being. But worldwide concern over the legitimacy of pharmaceuticals has increased markedly in the last three years. At an open forum attended by representatives of the Ministry of Health and private sector on Thursday in Sharjah, a representative pharmaceutical company Pfizer, said there is still a threat in the Middle East despite recent initiatives to curb illicit trade in fake – and potentially harmful – medicines.

“There are lots of initiatives (being taken) against counterfeiting here. But we cannot say that Middle East region is free of fake medicines, especially because of the presence of many free trade zones here,” Steve Allen, Europe and MENA Senior Director of Global Security for Pfizer, said. “Just a year ago, we had found counterfeited Lipitor in the retail chain here.” The World Health Organisation’s International Medical Products Anti-Counterfeiting Taskforce (IMPACT) estimates that fake pharmaceuticals – medicines produced by unlicensed manufacturers and introduced directly into the global supply chain –make up one per cent of drug sales in developed countries and approximately 30 per cent in some countries in Asia, Africa and Latin America. A British investigation in January into how the anti-psychotic drug, Zyprexa, entered the national health system highlighted the problem. Some reports suggested that drugs may have found their way into the United Kingdom in shipments that originated in China and passed through UAE ports.

The UAE’s Role: Dubai sits at the nexus of several transit points. Goods from Africa and Asia bound for the rest of the world pass through the city’s ports at a fast pace. This pace – approximately six hours for sea cargo to be checked, driven through Dubai’s roads and put on an outbound plane – appeals to people trying to ship illicit goods, according to Mohammad Al Mari, head of the Intellectual Property Rights Section of Dubai Customs.

“It’s not the location, it’s the infrastructure we have developed,” he said. Al Mari said he liked the pace, especially just a few years ago when the sea to air transfer time was one-third of today’s.” “It used to be fun, but not anymore with the traffic,” Al Mari said, smiling. But the speed is also the reason for his concerns. It has “given people the impression of using an easier, proper supply chain.”

Health and Customs officials in the UAE say they are working to counteract this impression with a set of new initiatives that include a national committee on counterfeit drugs established in January, portable devices for use at entry points to detect drugs and a proposal to increase the number of drug inspectors. The chair of the new national committee and the CEO of Medical Practice and Licence at the Ministry of Health, Dr. Amin Al Amiri, said the committee will extend its reach beyond the pharmaceuticals used to treat chronic conditions like diabetes, hypertension and cardiovascular diseases preferred by counterfeiters to medical devices and food supplements. “It is not just the fake medicines that pose a threat to public health. We need to prevent fake medical devices and food supplements, too,” Al Amiri said. “That is why the committee wants to monitor the import and export of medical devices and food supplements as well.”

The Ministry of Health requires all companies importing prescription, non-prescription and veterinary medicines to obtain a permit and send a copy to the Customs officials. Companies using the UAE’s ports to move these products also have to register. Al Amiri said the Ministry of Health (MoH) last month mandated pre-registration for food supplements and medical devices. “We have stringent procedures for registrations. Manufacturing companies have to produce a lot of certificates,” he said. Customs officials do not typically release medical shipments from port entry points until a trained pharmacist from MoH checks the shipment.

Al Mari said 70-80 per cent of the drugs entering Dubai’s ports are sampled and sent for testing at MoH’s drug control lab in Abu Dhabi. To ensure that the other cargo does not contain illicit imports, Al Mari said Dubai Customs fully offloads and inspects five to seven per cent of all cargo passing through the emirate. Twelve per cent of shipments are scanned. At certain spots, there are tougher regulations. At the dhow site for sea cargo, 100 per cent of all vessels are inspected. Al Amiri said companies have been given a grace period of six months to register their products. From June, shipments with unregistered drugs, devices and supplements will not be allowed entry in the UAE. “As of now, we are releasing the shipment, but we will not allow it go to the market unless the company registers the products within six months. It is for the protection of the community and to have best quality products in the country. We don’t want anything to enter the country unless it is registered and regulated.” The threat at home: Al Amiri said it was difficult to quantify the threat posed by counterfeit pharmaceuticals. “We don’t have a figure for the UAE. But we presume the threat of counterfeiting of mainly the drugs for chronic diseases, such as diabetes and hypertension, because of their wide use, and some other expensive pills,” he said. “We have never detected anything that is very dangerous or lethal. So far, a few of the drugs related to hypertension have been confiscated.” In 2008, Dubai Customs found only one instance of fake product: counterfeit hand cream. Recently, the UAE changed several policies in an effort to protect local residents. If inspectors suspect any item to be fake, it will be immediately reported to the police and sent to the drug inspection section for investigation. Non-registered drugs, once confiscated here, have to be sent back to the country of origin. “We have introduced this new system,” Al Amiri said. “We don’t allow any unwanted drugs to be destroyed here in our land. We don’t want any adverse impact to our environment and public health due to this.”

The UAE has also banned drug repackaging, once done on Emirati soil. “Some companies used to bring some of the non-registered drugs, repack it here and export it to some other countries. When they confiscate these, they think that all those drugs went from here which resulted in negative reputation to the UAE. We have stopped that practice and strictly banned the repackaging of medicines.”

Steve Allen from Pfizer said drug counterfeiting should be punishable more severely than in IPR violations because of the damages they cause. “It is not just about piracy like in the case of counterfeit CDs. Fake medicines can kill people and their trade is an organised crime,” Allen pointed out.

Private investigators employed by big pharmaceutical companies like Pfizer alert regulatory bodies about the entry of fake medicines into the market and any breach in the supply chain. “We would like the Customs to have the same level of focus on counterfeit medicines as on narcotics. Narcotic drug addicts know what they are taking and its potential dangers,” he said. “But it’s innocent patients whose health is affected because of counterfeit prescription drugs. Some can be lethal. We have found rat poison, boric acid and inkjet cartridges in some fake drugs.” About 20 Pfizer products are counterfeited worldwide with Lipitor, Norvasco and Viagra topping the list. Allen said counterfeiters were shifting focus to life-saving from lifestyle medicines because of expected delays in response. Anwar Hussain, assistant manager for purchases and R &D with the Medshop pharmacy chain, presented a paper on health hazards of fake drugs at Thursday’s forum. He called on pharmacists to buy medicines from authorised agents. “Pharmacists should ensure that all products are supplied against valid invoices stating the batch numbers. They should watch out for the products offered at high bonuses or extra discounts by unauthorised suppliers, monitor warnings from manufacturers and look out for pricing labels approved by the MoH.”

Wednesday, February 18, 2009

Over 120 kgs (265 lbs) of Fake Viagra Bound for America and Europe Seized

One of the largest seizures of Fake Viagra occurred this week in India. A local organization Enforcers of Intellectual Property Rights (EIPR) supplied the police with months of data on the illegal manufacturing and aided the authorities in their investigation.

On 4:00 p.m. Saturday, February 14, 2009 Haryana (India) police raided a supposedly closed manufacturing plant and seized 200 kgs. (440 lbs.) of counterfeit medicine, including 120 kgs. (265 lbs.) of fake Viagra.

The police found evidence that the Viagra drug was being manufactured on site and found the active ingredient of Viagra, sildenafil citrate, in its raw material form as well as packaged products ready for shipping. The spurious drugs were allegedly bound for shipment to the United States, Europe, and Canada.

The Indian police arrested eight people who were working at the company called Chem Pharma Company and are likely to press charges against them and the owner of the company Mr. Bhardwaj.

The investigation is continuing and more raids and arrests are anticipated. A majority of fake erectile dysfunction (ED) medication like Viagra is thought to be produced in India, Pakistan and China. These operations often involve underground criminal organizations which have been linked to terrorist activity around the world.

Due to this recent threat to public health, XStream Systems would caution consumers to buy ED medications only from licensed pharmacists and avoid online purchases from sources other than those supported by actual brick-and-mortar pharmacies. Wholesalers and distributors should verify inventory received. Given the sophistication of this batch of counterfeit drugs molecular authentication methods would be the best countermeasure to block any counterfeit products from entering their business.

Friday, January 16, 2009

Counterfeit Drugs – The Silent Killer of Our Time?

Don’t do the Crime unless you can do the Time – At least that is how the saying goes. But what kind of deterrent is a relatively short sentence vs. the potential loss of thousands of lives?

Recently Mr. Kevin Xu, a known counterfeiter from China was sentenced for his role in a massive plan to distribute counterfeit drugs here in the United States.

He sold counterfeit drugs to U.S. citizens via the Internet. The income from the sales in the U.S. in 2007 totaled $232,568.

His next step was to make inroads into the legitimate supply chain. In negotiations with undercover agents he thought were potential buyers, he listed 25 drugs he could manufacture. These medications included Tamiflu, Plavix, Zyprexa, Aricept and Casodex. What’s more, the samples he provided to “the buyers” looked identical to the real pills.

His plan was ultimately foiled by the undercover agents from U.S. Immigration and Customs Enforcement (ICE) and U.S. Food and Drug Administration(FDA).

In their investigation, agents also learned that Xu distributed counterfeit pharmaceuticals in the United Kingdom which had penetrated the legitimate supply chain in London, and prompted a massive recall for Zyprexa, Plavix and Casodex by the Medicines Health and Regulatory Agency in London, England.

Xu received more than $1.5 million from selling counterfeit pharmaceuticals globally in 2007 alone, yet his sentence was only 6 ½ years!

Saturday, January 3, 2009

Counterfeit Drug Definition Absent from Agenda of WHO Executive Board Meeting


Currently the World Health Organization definition of a counterfeit medication definition reads as:

"A counterfeit medicine is one which is deliberately and fraudulently mislabeled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products and counterfeit products may include products with the correct ingredients or with the wrong ingredients, without active ingredients, with insufficient (inadequate quantities of) active ingredient(s) or with fake packaging."

Once again, bowing to pressure from some member countries, the WHO's Executive Board has left the important issue of counterfeit medication definition off the agenda for its meeting in January 2010 because of controversy surrounding the definition of counterfeit medication.
The WHO contends that a strong, consistent definition of counterfeit is necessary in order to develop global strategies to combat the problem and has been engaged for some time in developing a standard definition that all member countries can agree on.

At the heart of the definition’s continued delay is the objection from countries like India and Brazil over the use of the term "counterfeit" and the contention that it will cause some legitimate generics manufactured in these countries to come under the WHO definition. Essentially these countries believe that drug manufacturers that own international intellectual property rights for medications will use the WHO definition as a legal tool against drug manufacturers in their countries which produce generic medications that may infringe on the intellectual property of companies globally.

These countries are delaying the issue within the Executive Board and continue to ask for a revised definition which would be more specific to falsified or substandard medicines.


The WHO is now hoping that this issue will be discussed at the 2010 World Health Assembly in May.


Although a definition seems trivial and simple to some, this is an important step forward in combating an important healthcare issue that impacts everyone globally. Without this definition, it is difficult for regulatory and law enforcement agencies to collaboratively and comprehensively work together on attacking counterfeit medications at their source. Basic agreement on what is or is not a counterfeit allows unscrupulous organizations and individuals the ability to usurp legal loopholes and to operate, hide and spread their dangerous wares throughout the globe.

Friday, November 21, 2008

Scales “Weigh In” and are Found Inadequate

By Brian Mayo, President and CEO, XStream Systems, Inc.

While analytical instruments work well in a forensic laboratory environment, the pharmaceutical industry is struggling to detect counterfeit medications throughout the distribution chain. Sophisticated analytical instruments typically require access to the exposed medications and a highly trained operator to interpret the results. But what about the warehouse worker handling sealed prescription medicine? How does he/she know if any counterfeit products have been received in the large shipments that have been received? The bottles cannot be opened, and the warehouse workers are clearly not trained well enough to operate the analyzers even if they could get access to the medicines inside the bottles.

Often times wholesalers, dispensers, and re-packagers settle for an inexpensive and fast solution: a scale that weighs the bottles. Bottles are simply checked by weighing them and verifying if the weight is proper. Unfortunately counterfeiters can and have been matching the weights contained within each prescription bottle. The industry is being lured into a false sense of security. Checks are being done along the way and everything appears ok. Only after passing through many hands and finally being opened does one discover the truth, that the contents inside are not what was expected. By that time, the counterfeiter is long gone and untraceable.

The war against counterfeits is always a cat and mouse game. As new methods of checking for counterfeits are created, new methods of avoiding it usually follow. Multiple protection measures may be required over time. Hopefully enough checkpoints are put into place to discourage counterfeiters, who then go off looking for easier prey elsewhere. Just take a close look at a $20 bill to see its layered checking methods such as the serial numbers, special inks, special paper, imbedded thread, holographic images, and fine print resolution. These have evolved over time, as the counterfeiting schemes became more sophisticated.

Unfortunately the pharmaceutical industry is now the easy prey. Here we are, in the 21st century, with many companies still relying on weighing bottles of drugs to protect the public against counterfeit drugs. Why? Well, for one thing when this was implemented, counterfeit drugs did not seem prevalent. Counterfeit drugs did not seem to be such a big problem. Now they are a $40B industry and growing rapidly. A second reason is that the right authentication technology has, until now, not been available.

The next phase of combating counterfeit drugs centers around three very important requirements.

1. There needs to be the ability to penetrate inside sealed bottles and packages to reveal what’s truly inside.

2. There needs to be an analytical tool that somehow determines exactly what the drug is, and not just simply how much it weighs.

3. The new method needs to be easily done by anyone, anywhere in the supply chain.
All three of these very important requirements are met by the XT250™ Material Identification System offered by XStream Systems. Any warehouse worker can rapidly and easily authenticate drugs inside sealed bottles, by automatically verifying the drug’s molecular structure.

The majority of counterfeit drugs detected so far by the XT250 system had previously passed the weighing test. This indicates that counterfeiters are well aware of the weighing process in the supply chain and successfully circumvented those checks. Now that the XT250 system is verifying the molecular structure of the drug, counterfeiters can only reproduce the actual drug to avoid detection by the XT250 system. The counterfeiter’s job just got a whole lot harder… Counterfeiters, it’s now your move.

Tuesday, July 8, 2008

Slim to None Chance for Unsuspecting Prescription Purchaser

A young British woman tragically died one day after starting a diet prescription she purchased online. Self-conscious about her weight she turned to the same destination many consumers with embarrassing conditions do – the internet pharmacy.

The lure of the internet pharmacy is anonymity... But, that is its danger also! These online stores do not always follow the same regulations and precautions as the brick and mortar drug stores do. They often do not require prescriptions or ask for current medications, and sometimes, as in this case, sell banned or unapproved medications.

A report by The European Alliance for Access to Safe Medicines (EAASM) stated that three out of five drugs purchased online are fakes and consumers were putting their health at risk when using them. Other disturbing statistics disclosed were:

• 95.6% of online pharmacies researched are operating illegally.
• 94% of websites do not have a named, verifiable pharmacist.
• Over 90% of websites supply prescription-only medicines without a prescription.
• 86% of online 'pharmacy approval' stamps are fake.

In this particular case, young 26-year-old Selena Walrond, from Croydon in South London was just looking for a slimmer version of herself. From a Chinese website she purchase DNP or dinitrophenol, a fat burning chemical which boast an increase of 50% in metabolic rate which can result in a 10 – 12 pound weight loss in just 8 days. The following day, Selena was found with a racing pulse and feverish. She was rushed to the hospital by her mother and died of cardiac arrest.

DNP is as dangerous as it is effective – making it one of the first drugs to be banned in the U.S. by The Food and Drug Administration (FDA) back in 1938 and it has never been approved in the United Kingdom (UK). The drugs side effects include sweats, insomnia, cataracts, and death.

Beware -- sometimes when a deal sounds too good to be true, it is and the costs can be more than you even imagined…..

Monday, July 7, 2008

Are Counterfeit Medicines on the Rise?

The prevalence of counterfeit medicines has often been thought as rare in developed countries. This view is changing and changing fast as seizures of counterfeits are on the rise overseas and here in the United States, but perhaps most alarming is the rate of which they are increasing as portrayed in a recent article in Bloomberg News.

According to Pharmaceutical Security Institute, an organization of 26 drug makers, seizures of counterfeits jumped 24 percent in 2007, which amounted to 403 different fake medications confiscated in 99 countries in 1,513 incidents.

Troubling is the fact that copies of 19 of the world’s 25 best-selling medications are among those seized by industry security, customs agents and police last year, according to data compiled by Bloomberg News.

These trends emphasize a need to strengthen our security measures here in the U.S. against an emerging sophisticated criminal element, which seeks to profit at the expense of our health.

We must take a proactive approach to secure our supply chain and most importantly protect our consumers!